Business

"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on the Influenza Virus Split Vaccine Obtaining Drug Registration Certificate and Passing GMP Compliance Inspection

"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on the Influenza Virus Split Vaccine Obtaining Drug Registration Certificate and Passing GMP Compliance Inspection

articleLiaoning Chengda Biotechnology Co. Ltd. Class AJuly 2, 20265/news/liaoning-chengda-biotechnology-co-ltdannouncement-on-the-influenza-virus-split-vaccine-obtaining-drug-registration-certificate-and-passing-gmp-compliance-inspection
"LIAONING CHENGDA BIOTECHNOLOGY CO., LTD."Announcement on the Influenza Virus Split Vaccine Obtaining Drug Registration Certificate and Passing GMP Compliance Inspection

About this update from Liaoning Chengda Biotechnology Co. Ltd. Class A

Announcement on the Influenza Virus Split Vaccine Obtaining Drug Registration Certificate and Passing GMP Compliance InspectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference:View Attachment

View stock analysis, news, and events for Liaoning Chengda Biotechnology Co. Ltd. Class A